Keurig Dr Pepper price target raised to $41 from $40 at JPMorgan

JPMorgan analyst Andrea Teixeira raised the firm’s price target on Keurig Dr Pepper to $41 from $40 and keeps an Overweight rating on the shares. The analyst sees a favorable risk/reward on the shares, saying the company has set the bar lower and is baking in a fair amount of conservatism for 2023 given macro uncertainty and a new CFO joining. JPMorgan views Keurig Dr Pepper’s valuation as "compelling" at current share levels.